Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study

Title
Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study
Authors
Keywords
Lobeglitazone, Thiazolidinediones, Clinical trial, Randomised trial
Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 110, Issue 3, Pages e27-e30
Publisher
Elsevier BV
Online
2015-09-22
DOI
10.1016/j.diabres.2015.09.009

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started